Alessandro Parisi

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 415 citations · Full text

Medicine, Immunology, Oncology +16

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Mark Bower, Lorenza Scotti et al. · The Lancet Oncology · 2021 · 136 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study

David J. Pinato, Daniela Ferrante, Georgina Hanbury et al. · The Lancet Oncology · 2022 · 80 citations · Full text

Medicine, Infectious Diseases, Oncology +16

Time-Dependent COVID-19 Mortality in Patients With Cancer

David J. Pinato, Meera Patel, Lorenza Scotti et al. · JAMA Oncology · 2021 · 72 citations · Full text

Medicine, Infectious Diseases, Oncology +10